Abstract
U-LFABP AS A PREDICTIVE MARKER FOR PROGNOSIS OF DIABETIC KIDNEY DISEASE IN EGYPTIAN PATIENTS

Eman M. Abd El Azeem*, Dina M. Seoudi, Mustafa I. Hassanein and Marwa A. Hussein

ABSTRACT

This study was aimed to evaluate the level of urinary liver-type fatty acid binding protein (u-LFABP) as a marker of diabetic kidney disease and to study its correlation with other kidney parameters in Egyptian patients with chronic type 2 diabetes mellitus (T2DM). A total of 70 T2DM subjects were divided into three groups: diabetics with normal kidney function and normal blood pressure (DM; 20 patients), diabetics with microalbuminureia and high blood pressure (early-DN; early diabetic nephropathy) (20patients) and diabetic kidney disease (DKD) with microalbuminuria and high blood pressure (30 patients), with 20 non-diabetic control subjects. U-LFABP levels were measured by ELISA technique. Results showed that u-LFABP level was highly significant increased (P<0.001), this increase was more pronounced in early DN group and in DKD patients compared to normal control indicating tubular damage. The levels of u-LFABP increased gradually with declining renal function and reduced e-GFR. U-LFABP showed a positive correlation with s- creatinine, UAER and IL-6 (r 0.55, 0.32 and 0.56; respectively) and a significant negative correlation with e-GFR (r= 0.54, P<0.05) in the early DN patients’ group. In DkD patients’ group a significant positive correlation was recorded between u-LFABP and fasting plasma glucose, HbA1c, fasting insulin, s- creatinine, UAER and IL-6 (r= 0.35, 0.57. 0.45, 0. 67, 0.70 and 0.77; respectively) and negative correlation with e-GFR (r= 0.66, P<0.001). As a result of receiver operating characteristic (ROC) analysis, u-LFABP appeared to be a more sensitive marker for the detection of early-DN and also for the prediction of DKD progression in diabetic patients.

Keywords: Diabetic nephropathy, u-LFABP, diabetic kidney disease.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2023 Issue has been successfully launched on 1 FEBRUARY 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT